QUVATE

This brand name is authorized in Nigeria.

Active ingredients

The drug QUVATE contains a combination of these active pharmaceutical ingredients (APIs):

1	Betamethasone UNII 9842X06Q6M - BETAMETHASONE
	Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties.
	Read more about Betamethasone
2	Gentamicin UNII 8X7386QRLV - GENTAMICIN SULFATE
	Gentamicin is usually bactericidal in action. Although the exact mechanism of action has not been fully elucidated, the drug appears to inhibit protein synthesis in susceptible bacteria by irreversibly binding to 30S ribosomal subunits.
	Read more about Gentamicin
3	Tolnaftate UNII 06KB629TKV - TOLNAFTATE
	Read more about Tolnaftate
4	Clioquinol UNII 7BHQ856EJ5 - CLIOQUINOL
	Read more about Clioquinol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D07CC01	Betamethasone and antibiotics	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07C Corticosteroids, combinations with antibiotics → D07CC Corticosteroids, potent, combinations with antibiotics
Discover more medicines within D07CC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100618
Switch country to Nigeria in order to find specific presentations of QUVATE